AngioDynamics (ANGO) Misses Q1 EPS by 4c, Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $82.58 million.

GUIDANCE:

AngioDynamics sees FY2023 EPS of $0.01-$0.06, versus the consensus of $0.02. AngioDynamics sees FY2023 revenue of $342-348 million, versus the consensus of $344 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• 374Water Inc (SCWO) Misses Q2 EPS by 15c